We're transitioning from building a pipeline to building a business." He highlighted the successful launch of PALSONIFY as the company's first commercial product and emphasized its label reflecting ...

Crinetics Pharmaceuticals (NASDAQ:CRNX) executives highlighted early commercial momentum for PALSONIFY, outlined a global phase II/III study plan for atumelnant in ACTH-dependent Cushing’s syndrome ...

Net Product Revenue of $5.4 Million for Fourth-Quarter 2025, with >200 Enrollment Forms at the End of December Operationally Seamless Phase 2/3 Study of Atumelnant for the Treatment of ACTH-Dependent ...

Midos Sujin Tonmainin, manufactured by Nam King Drugs Malaysia was found to be adulterated with Dexamethasone/Betamethasone.

A recent longitudinal cohort study shows a statistically significant relationship between body image disturbance, pain, and persistent depression in patients with Cushing syndrome.

Parry-Romberg Syndrome (PRS), a rare autoimmune disorder that gradually destroys soft tissue on one side of the face.

Cortisol mobilizes sugar for you while insulin stores sugar. When you don’t have enough of it, you end up with low sugar and, ...

Scientists from Duke-NUS Medical School, working with collaborators at Imperial College London and partners in Europe and the United States, have uncovered new insights into how an additional copy of ...

Genetic data show that 14 psychiatric diagnoses cluster into five families of shared risk, explaining why conditions like ...

On the occasion of Rare Disease Day, the Biofisika Institute (CSIC, EHU) presents the progress of a project aimed at understanding the molecular origin of CTNNB1 neurodevelopmental syndrome, a rare ...